Explore the Latest Tenofovir Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Tenofovir Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Tenofovir Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Tenofovir Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Tenofovir Tenders and beyond.
6874453Open House Original Discount Contracts 2025-01 - Bictegravir/Emtricitabine/Tenofovir alafenamide (Biktarvy(R))Country: GermanyDeadline28 Feb 20276881224Title : Open House Original Discount Agreements 2025-02- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (Genvoya(R))Country: GermanyDeadline28 Feb 20276882340Open House Original Rebate Agreements 2025-05 - Emtricitabine/Tenofovir disoproxil/Rilpivirine (active ingredient combination)Country: GermanyDeadline28 Feb 20276883557Open House Original Discount Contracts 2025-04 - Emtricitabine/Tenofovir alafenamide/Rilpivirine (Odefsey(R))Country: GermanyDeadline28 Feb 20276945395Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for medicinal products containing the active ingredient combination of emtricitabine, riCountry: GermanyDeadline25 Jan 202710558810Lamivudine, tenofovir disoproxil and doravirineCountry: GermanyDeadline06 Dec 202710963274Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for drugs with the active ingredient combination of lamivudine, tenofovir disoproCountry: GermanyDeadline28 Dec 202712393202Open house drug discount agreements for the active ingredients lamivudine tenofovir disoproxil and doravirine atc j05ar24Country: GermanyDeadline01 Apr 202813380606Suministro de Fitomenadiona (DOE), Omeprazol (DOE),Ritonavir (DOE), Anidulafungina (DOE), Levofloxacino (DOE) y Asociación de Efavirenz (DOE), Emtricitabina (DOE) y Tenofovir DisoCountry: AndorraDeadline14 Sep 202613493254Open House Original Discount Agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (combination of active ingredients)Country: GermanyDeadline30 Nov 202713630499Open House Original Discount Agreements 2025-32 - Doravirin/Lamivudine/Tenofovir (combination of active ingredients)Country: GermanyDeadline30 Nov 202713874255Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Emtricitabin + Rilpivirin + Tenofovir disoproxil fumarat, ATC J05AR08 für die Zeit 01.0Country: GermanyDeadline04 Jul 202814088343Trifluridine plus Tipiracil 20 mg per 8 19 mg Tab Tab Tenofovir 300mg plus Lamivudine 300 mg plus DCountry: IndiaDeadline10 Aug 202614189574Suministro de Ganciclovir,Epoprostenol,Levetiracetam,Meropenem,Asoc Emtricitabina/Tenofovir disop,Tobramicina,Abacavir,Sunitinib,Irinotecan,Lapatinib,Dalbavancina,Nintedanib y TrieCountry: SpainDeadline04 Sep 2026
